This company has been marked as potentially delisted and may not be actively trading. Vaccitech (VACC) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisCompetitorsHeadlinesInsider TradesOwnershipTrendsBuy This Stock Vaccitech (NASDAQ:VACC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.00%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$60,975.00Number OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)$147,830.24 Get VACC Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaccitech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VACC Insider Buying and Selling by Quarter Vaccitech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/26/2023Joseph ScheerenDirectorBuy10,000$2.44$24,400.00 5/25/2023Robin WrightDirectorBuy13,750$2.66$36,575.00 3/27/2023William EnrightCEOSell15,000$2.42$36,300.00 8/25/2022Graham GriffithsInsiderSell10,000$7.39$73,900.00 8/24/2022Christopher EllisCOOSell450$4.78$2,151.00 8/18/2022Christopher EllisCOOSell2,175$4.84$10,527.00 8/17/2022Graham GriffithsInsiderSell500$4.76$2,380.00 8/12/2022Graham GriffithsInsiderSell5,000$4.50$22,500.00 6/28/2022Christopher EllisCOOSell5$6.00$30.00 6/23/2022Graham GriffithsInsiderSell8$5.28$42.24 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) VACC Insider Trading Activity - Frequently Asked Questions Who is on Vaccitech's Insider Roster? The list of insiders at Vaccitech includes Christopher Ellis, Graham Griffiths, Joseph Scheeren, Robin Wright, and William Enright. Learn more on insiders at VACC. What percentage of Vaccitech stock is owned by insiders? 6.00% of Vaccitech stock is owned by insiders. Learn more on VACC's insider holdings. Which Vaccitech insiders have been buying company stock? The following insiders have purchased VACC shares in the last 24 months: Joseph Scheeren ($24,400.00), and Robin Wright ($36,575.00). How much insider buying is happening at Vaccitech? Insiders have purchased a total of 23,750 VACC shares in the last 24 months for a total of $60,975.00 bought. More Insider Trading Tools from MarketBeat Related Companies Tonix Pharmaceuticals Insider Buying Enanta Pharmaceuticals Insider Buying Neoleukin Therapeutics Insider Buying OptiNose Insider Buying Zentalis Pharmaceuticals Insider Buying Coya Therapeutics Insider Buying Oramed Pharmaceuticals Insider Buying Anixa Biosciences Insider Buying Pliant Therapeutics Insider Buying Climb Bio Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:VACC) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccitech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccitech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.